Searchable abstracts of presentations at key conferences in endocrinology

ea0020p633 | Reproduction | ECE2009

Advanced glycosylated end products are associated with anovulatory markers in women with polycystic ovary syndrome

Diamanti-Kandarakis Evanthia , Piouka Athanasia , Livadas Sarantis , Piperi Christine , Katsikis Ilias , Papavasiliou Athanasios , Panidis Dimitrios

Background: Chronic anovulation constitutes one of the cardinal features of Polycystic Ovary Syndrome (PCOS) and Anti-Müllerian hormone (AMH), a granulosa cell product, is a well documented marker of anovulation. Recent data have shown that oxidative stress is involved in the pathophysiology of anovulation. A marker of oxidative stress, Advanced Glycosylated End products (AGEs), is implicated to the pathogenesis of the syndrome and have been localized with high intensity ...

ea0020p489 | Obesity and Metabolism | ECE2009

Effect of pharmaceutical intervention on serum levels of advanced glycated end products in women with polycystic ovary syndrome

Diamanti-Kandarakis Evanthia , Christakou Charikleia , Piperi Chistina , Kandaraki Eleni , Katsikis Ilias , Adamopoulos Christos , Papavasiliou Athanasios G , Panidis Dimitrios

Background: Polycystic ovary syndrome (PCOS) is associated with obesity and insulin resistance, two major contributors to cardiovascular risk. Even in the absence of detectable insulin resistance, lean, non-diabetic PCOS women demonstrate increased circulating levels of advanced glycated end products (AGEs), known proatherogenic molecules. This adverse cardiovascular risk profile should be considered in the syndrome’s management.Objective: To invest...